Smartlab Europe

Press Releases

Switzerland partners with Bio Asia2020; seeks closer ties with Indian Lifesciences industry

Switzerland, consistently ranked no.1 in innovation, is widely known for innovation in big pharma with the presence of eminent pharma and life-sciences companies like Novartis, Roche, Lonza, Ferring Pharma, etc. The country is looking to forge closer ties with...

Sharp Strengthens Senior Leadership Team with Two Appointments

Sharp, a part of UDG Healthcare and a leading provider of pharmaceutical packaging and clinical services, has strengthened its senior leadership team with two new additions. Walter Tyrrell has been appointed as chief financial officer and Robert O’Beirn as senior...

Clinerion partners with Eugen to expand Patient Network Explorer coverage to patients and hospitals in Uruguay

Eugen, a clinical development service provider based in Uruguay, will support Clinerion’s expansion by promoting hospitals in the country to join Patient Network Explorer (PNEx), adding to the platform true global representativeness. They will use PNEx to provide clients with...

SWISSPORT Opens Pharma Center in Brussels

Swissport International has opened its state-of-the-art Pharma Center for temperature-sensitive cargo shipments at Brussels Airport. The new facility offers 3,620 sqm of temperature-controlled warehouse space, providing clients with an end-to-end cool chain. Once completed the cargo complex will boast...

Thermo Fisher Scientific Unveils $6 Million Expansion at Viral Vector Manufacturing Facility

Thermo Fisher Scientific, the world leader in serving science, unveiled the $6 million expansion of its gene therapy and viral vector services site in Alachua, Florida. The investment doubles the site’s laboratory and warehousing capacity for upstream process development...

Novartis opens new cell and gene therapies facility in Switzerland

Swiss pharmaceutical company Novartis has opened a new manufacturing facility for cell and gene therapies at Stein in Switzerland. The new facility also facilitates the production of advanced and difficult-to-manufacture solid dosage forms such as tablets and capsules, in addition...

Recipharm announces commercial manufacturing to support Talicia® Q1/2020 launch following U.S. FDA approval

Recipharm, the contract development and manufacturing organisation , announced ongoing large-scale commercial manufacturing of RedHill Biopharma’s drug, Talicia delayed-release capsules 10 mg /250 mg/12.5 mg, for its planned launch in the first quarter 2020. RedHill and Recipharm have been working...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »